| 21.69 Delayed Data As of Mar 18 |  +0.69 / +3.29%Today’s Change | 5.12 Today|||52-Week Range 25.10 | +108.76% Year-to-Date |
| Previous close | 21.00 |
| Today’s open | 21.00 |
| Day’s range | 20.99 - 21.75 |
| Volume | 6,403,077 |
| Average volume (3 months) | 14,396,241 |
| Market cap | $6.9B |
| Earnings growth (last year) | +174.49% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +608.57% |
| P/E ratio | NM |
| Price/Sales | 437.01 |
| Price/Book | 45.37 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARGXargenx SE | +1.53 | +1.16% |
| APHAAphria Inc | +0.64 | +6.67% |
| USNAUSANA Health Science... | -0.71 | -0.77% |
| HEXOHexo Corp | +0.62 | +10.15% |
| Next reporting date | March 26, 2019 |
| EPS forecast (this quarter) | -$0.00 |
| Annual revenue (last year) | $3.1M |
| Annual profit (last year) | $1.9M |
| Net profit margin | 61.02% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Michael Gorenstein |
Chief Operating Officer David Hsu |
Corporate headquarters Toronto, Ontario |
